Two cases of bacterial meningitis due to meropenem-resistant Streptococcus pneumoniae: A threat of serotype 35B, ST 558 lineage

Although the pneumococcal conjugate vaccine (PCV) has decreased the incidence of invasive pneumococcal disease (IPD) in children, cases of IPD caused by non-PCV serotypes have been increasing. Here, we report two cases of bacterial meningitis caused by meropenem-resistant Streptococcus pneumoniae; i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2020-07, Vol.26 (7), p.745-748
Hauptverfasser:	Yamada, Nami, Nakamoto, Takato, Takei, Haruka, Shoji, Takayo, Takahashi, Kaori, Sato, Junichi, Takeuchi, Noriko, Ohkusu, Misako, Ishiwada, Naruhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Bacterial meningitis beta-Alanine - analogs & derivatives beta-Alanine - pharmacology beta-Alanine - therapeutic use Cefotaxime - pharmacology Cefotaxime - therapeutic use Drug Resistance, Multiple, Bacterial - genetics Female Humans Infant Male Meningitis, Pneumococcal - blood Meningitis, Pneumococcal - diagnosis Meningitis, Pneumococcal - drug therapy Meningitis, Pneumococcal - microbiology Meropenem - pharmacology Meropenem - therapeutic use Meropenem-resistant Streptococcus pneumoniae Microbial Sensitivity Tests Multilocus Sequence Typing Pneumococcal Vaccines - administration & dosage Serotype 35B Serotyping Streptococcus pneumoniae - drug effects Streptococcus pneumoniae - genetics Streptococcus pneumoniae - isolation & purification Thienamycins - pharmacology Thienamycins - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!